Home / Hematology
Hematology
| 2 min read
Asterand plc announced last month an exclusive licensing agreement with Allergan Inc. to develop and commercialize a series of Asterand’s proprietary compounds with ophthalmic indications.
| 3 min read
IonGate taps Artel to spearhead adoption and application of SURFE²R technology in North America
| 2 min read
Sophic and Biomax receive funds to complete NCI's Cancer Gene Index Project
| 2 min read
Roche, PsychoGenics team up to identify neuropsyciatric disorder treatments
| 2 min read
$23 million deal creates company focused on molecular chaperone technology platform, near-term oncology opportunities
| 2 min read
Researchers from the Stanford University School of Medicine have discovered that lowering levels of a cancer signal under a specific threshold—much like a light dimmer switch—reverses tumor development in mice, according to a study published in the July 1 issue of Cancer Research.
| 2 min read
Invitrogen Corp., which has been steadily building its cell therapy expertise, announced in mid-May the formation of a separate cell therapy business unit focused on the specific needs of the clinical cell therapy market.
| 2 min read
A study led by Ohio State University researchers shows that a gene mutation present in some cases of leukemia could improve the performance of the anti-cancer drug cytarbine.
| 2 min read
The Parkinson’s Institute, 23andMe launch Web-based research initiative
| 2 min read
Affymetrix extends Collaborations in Cancer Research Program to North American region
